Surveying children and adult vaccination program against diphtheria, tetanus, measles and viral hepatitis B in the Russian Federation

Cover Page

Cite item

Abstract

Over the last years, incidence of vaccine-preventable infections tended to increase both in Russia and multiple European countries due to diverse reasons, including loss of alertness in medical workers to ensure proper quality of immunization. Currently, vaccination is considered to be the most efficient means for preventing infectious diseases. However, vaccination efficacy is directly related to population coverage and proper timeframe for its application.

Materials and methods. Diphtheria, tetanus, measles and hepatitis B vaccination coverage and timeframe were analyzed for population of Russia, Moscow as well as the three pediatric and adult out-patient hospitals.

Results. It was found that compared to adults, pediatric subjects were vaccinated better. However, in case of 95% or higher coverage against all infections, shortcomings in vaccination timeframe were uncovered. In 2017, despite pediatric subjects should be vaccinated against diphtheria and tetanus at the age of 3-to-6 months, coverage was as low as 46.9% in Russia, 48.7% in Moscow that ranged in some polyclinics from 21.8% in 2012 down to 1.7% in 2017. Moreover, this situation was even more unfavorable in case of revaccination program. In particular, it was found that at the age of 18 months only 50, 54, and 49–55% underwent revaccination in the Russia, Moscow 54%, and some out-patient hospitals, whereas at the age of 7–14 years in Russia there were revaccinated up to 97% population. Likewise, at the age of 6 months there were covered with vaccination against hepatitis B as few as 49% population in Russia and Moscow, whereas more than 90% coverage was achieved only at the age of 1 year. Immunization coverage reaching more than 85% of adult population against hepatitis B is superior to diphtheria and tetanus. Immunization coverage against measles in Russia at all age groups was over 90% population. Thus, it is necessary to optimize activities on adhering to vaccination timeframe, as decline in quality of vaccination inevitably leads to elevated incidence rate of vaccine-preventable infections. This and vaccination coverage might be adjusted by introducing a Preventive Vaccination Surveillance and Reporting Automated System in the Russian Federation.

About the authors

N. P. Galina

Sechenov First Moscow State Medical University

Author for correspondence.
Email: greenday_billie@mail.ru

Natalia P. Galina, Laboratory Assistant, Department of Epidemiology and Evidence-Based Medicine

119991, Moscow, Trubetskaya str., 8, bldg 2.

Phone: +7 962 939-25-53 (mobile).

Russian Federation

A. Ya. Mindlina

Sechenov First Moscow State Medical University

Email: mindlina@list.ru
ORCID iD: 0000-0001-7081-3582

PhD, MD (Medicine), Associate Professor, Professor, Department of Epidemiology and Evidence-Based Medicine

Moscow 

Russian Federation

R. V. Polibin

Sechenov First Moscow State Medical University

Email: polibin@bk.ru
ORCID iD: 0000-0003-4146-4787

PhD (Medicine), Associate Professor, Department of Epidemiology and Evidence-Based Medicine

Moscow 

Russian Federation

References

  1. Белов А.Б. Дифтерия: уроки прошлых эпидемий и перспективы контроля эпидемического процесса // Эпидемиология и вакцинопрофилактика. 2012. Т. 66, № 5. С. 12–19.
  2. Белов А.Б., Казаков А.Н. Эпидемиология и профилактика дифтерийной инфекции в войсках (на флоте). Санкт-Петербург: ВМедА, 2000. 76 с.
  3. Брико Н.И., Фельдблюм И.В. Иммунопрофилактика инфекционных болезней в России: состояние и перспективы совершенствования // Эпидемиология и вакцинопрофилактика. 2017. Т. 93, № 2. С. 4–9. doi: 10.31631/2073-3046-2017-16-2-4-9
  4. Ильина С.В. О профилактических прививках, инфекционных болезнях и мере ответственности // Педиатрическая фармакология. 2016. Т. 3, № 13. С. 285–288. doi: 10.15690/pf.v13i3.1579
  5. Кригер Е.А., Самодова О.В., Рогушина Н.Л., Борисова Т.А. Отношение родителей к вакцинации детей и факторы, связанные с отказом от прививок // Педиатрия. 2016. Т. 2, № 95. С. 91–95.
  6. Лопушов Д.В., Трифонов В.А., Сабаева Ф.Н., Фазулзянова И.М., Шайхразиева Н.Д. Оценка информированности медицинских работников по вопросам нежелательных поствакцинальных явлений // Пермский медицинский журнал. 2017. Т. 34, № 4. С. 82–88. doi: 10.17816/pmj34482-88
  7. Максимова Н.М., Маркина С.С., Яцковский К.А., Кошкина Н.А. Развитие эпидемического процесса дифтерии в России в условиях высокого уровня специфического иммунитета // Медицинский альманах. 2009. Т. 7, № 2. С. 105–108.
  8. О внесении изменений и дополнений в Приказ Минздрава России от 27.06.2001 г. № 229 «О Национальном календаре профилактических прививок и календаре профилактических прививок по эпидемическим показаниям». Приказ Минздравсоцразвития РФ № 673 от 30.10.2007 г.
  9. О реализации «Программы ликвидации кори в Российской Федерации к 2010 году» в 2008 году. Письмо Роспотребнадзора № 01/13123-9-23 от 09.09.2009 г.
  10. Селезнева Т.С., Заргарьянц А.И. Состояние заболеваемости корью на территории Российской Федерации в современных условиях // Эпидемиология и вакцинопрофилактика. 2009. Т. 45, № 2. С. 15.
  11. Цвиркун О.В., Герасимова А.Г., Тихонова Н.Т., Ежлова Е.Б., Мельникова, Дубовицкая Е.Л., Орлова О.С., Басов А.А., Фролов Р.А. Заболеваемость корью в разных возрастных группах в период элиминации инфекции // Эпидемиология и вакцинопрофилактика. 2017. Т. 94, № 3. С. 18–24. doi: 10.31631/2073-3046-2017-16-3-18-25
  12. Яковлева Т.В. Вакцинопрофилактика: достижения и проблемы. Эпидемиология и вакцинопрофилактика. 2009. Т. 49, № 6. С. 36–38.
  13. Keegan R., Dabbagh A., Strebel P.M., Cochi S.L. Comparing measles with previous eradication programs: enabling and constraining factors. J. Infec. Dis., 2011, vol. 204, рр. 54–61. doi: 10.1093/infdis/jir119
  14. Kouadio I.K., Kamigaki T., Oshitani H. Measles outbreaks in displaced populations: a review of transmission, morbidity and mortality associated factors. BMC Int. Health Hum. Rights, 2010, vol. 5, no. 10, рр. 1–11. doi: 10.1186/1472-698X-10-5
  15. Muscat M. Who gets measles in Europe? J. Infec. Dis., 2011, vol. 204, no. 1, рр. 353–365. doi: 10.1093/infdis/jir067
  16. Weekly Epidemiological Record (WER). 29 April 2011, vol. 86, no. 18, pp. 173–176
  17. World Health Organization. Immunization coverage, fact sheets, 2018.
  18. World Health Organization. Immunization.Vaccines and Biologicals. State of the world’s vaccines and immunization. Third edition.
  19. World Health Organization. Measles, fact sheets, 2018.
  20. World Health Organization. Proceedings of the global technical consultation to assess the feasibility of measles eradication, 28–30 July 2010. J. Infec. Dis., 2011, vol. 204, рр. 4–13. doi: 10.1093/infdis/jir100

Supplementary files

There are no supplementary files to display.


Copyright (c) 2019 Galina N.P., Mindlina A.Y., Polibin R.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies